Publications: 36, Peer-reviewed articles: 35, H-index: 8, Citations: 302, Scientific meeting presentations (oral): ?
Member of the National Board of Health committee for experimental cancer treatment
Member of three Danish Multidiciplinary Groups for, respectively, pancreatic cancer, liver tumours and gastro-esophageal tumors
Past president and current secretary for Scandinavian Network for Hepatocellular Carcinoma
Member of the National Board of Health committee (RADS) for treatment of neuroendocrine tumors
Member of the National Board of Health committee for follow-up of patients with upper gastro-intestinal tumors
Member of the Nordic Network for Neuroendocrine Tumors
Supervisor for 3 PhD. students
2 completed and 1 ongoing
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, B. E., Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, J., Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B. & Lassen, U., Dec 2023, In: BMC Cancer. 23, 1, 182.Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer
Ladekarl, M., Rasmussen, L. S., Kirkegård, J., Chen, I., Pfeiffer, P., Weber, B., Skuladottir, H., Østerlind, K., Larsen, J. S., Mortensen, F. V., Engberg, H., Møller, H. & Fristrup, C. W., Mar 2022, In: Acta Oncologica. 61, 3, p. 277-285 9 p.Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer
Steiniche, T., Rha, S. Y., Chung, H. C., Georgsen, J. B., Ladekarl, M., Nordsmark, M., Jespersen, M. L., Kim, H. S., Kim, H., Fein, C., Tang, L. H., Wu, T., Marton, M. J., Peter, S., Kelsen, D. P. & Ku, G., Dec 2021, In: Cancer Medicine. 10, 23, p. 8365-8376 12 p.Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A. C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C., Drivsholm, L. B., Vesteghem, C., Christensen, H. S., Bjørnhart, B. & Pøhl, M., Oct 2021, In: Cancers. 13, 19, 13 p., 4846.Clinically decisive (dis)agreement in multidisciplinary team assessment of esophageal squamous cell carcinoma; a prospective, national, multicenter study
Achiam, M. P., Nordsmark, M., Ladekarl, M., Olsen, A., Loft, A., Garbyal, R. S., Larsen, M. H., Ainsworth, A. P., Kristensen, T. S., Dikinis, S., Kjær, D. W., Bæksgaard, L., Siemsen, M., Nielsen, M. B., Schlander, S., Kramer, S., Katballe, N., Kruhlikava, I., Tabaksblat, E., Fisker, R. V., Mortensen, P. B., Holtved, E., Eckardt, J., Detlefsen, S., Naujokaite, G. & Lütken, C. D., Sept 2021, In: Acta Oncologica. 60, 9, p. 1091-1099 9 p.Merkelcellekarcinom
Naseri, S., Steiniche, T., Ladekarl, M., Hölmich, L. R., Langer, S. W., Tabaksblat, E., Junker, N. & Chakera, A. H., Jul 2021, In: Ugeskrift for Læger. 183, 30, 9 p., V03210260.Patterns of Palliative Chemotherapy and Survival in Patients with Pancreatic Cancer Focusing on Age: A Nationwide Real-World Danish Registry Study
Rasmussen, L. S., Fristrup, C. W., Jensen, B. V., Pfeiffer, P., Weber, B., Yilmaz, M. K., Poulsen, L., Ladekarl, M., Østerlind, K., Larsen, J. S., Skuladottir, H., Bøgsted, M. & Falkmer, U. G., May 2021, In: Pancreas. 50, 5, p. 685-695 11 p.Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
Pommergaard, H. C., Nielsen, K., Sorbye, H., Federspiel, B., Tabaksblat, E. M., Vestermark, L. W., Janson, E. T., Hansen, C. P., Ladekarl, M., Garresori, H., Hjortland, G. O., Sundlöv, A., Galleberg, R., Knigge, P., Kjaer, A., Langer, S. W. & Knigge, U., May 2021, In: Journal of Neuroendocrinology. 33, 5, 12 p., e12967.PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
Ali, A. S., Langer, S. W., Federspiel, B., Hjortland, G. O., Grønbæk, H., Ladekarl, M., Welin, S., Weber Vestermark, L., Arola, J., Osterlund, P., Knigge, U., Sørbye, H., Micke, P., Grimelius, L., Grönberg, M. & Tiensuu Janson, E., Dec 2020, In: PLOS ONE. 15, 12, 12 p., e0243900.International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis
Díaz-González, Á., Sanduzzi-Zamparelli, M., da Fonseca, L. G., Di Costanzo, G. G., Alves, R., Iavarone, M., Leal, C., Sacco, R., Matilla, A. M., Hernández-Guerra, M., Aballay Soteras, G., Wörns, M. A., Pinter, M., Varela, M., Ladekarl, M., Chagas, A. L., Mínguez, B., Arenas, J. I., Granito, A., Sánchez-Torrijos, Y., Rojas, Á., Rodríguez de Lope, C., Alvares-da-Silva, M. R., Pascual, S., Rimassa, L., Lledó, J. L., Huertas, C., Sangro, B., Giannini, E. G., Delgado, M., Vergara, M., Perelló, C., Lue, A., Sala, M., Gallego, A., Coll, S., Hernáez, T., Piñero, F., Pereira, G., França, A., Marín, J., Anders, M., Mello, V., Lozano, M., Nault, J. C., Menéndez, J., García Juárez, I., Bruix, J. & Reig, M., Jun 2020, In: Liver International. 40, 6, p. 1467-1476 10 p.Acute pancreatitis as an early marker of pancreatic cancer and cancer stage, treatment, and prognosis
Kirkegård, J., Gaber, C., Lund, J. L., Hinton, S. P., Ladekarl, M., Heide-Jørgensen, U., Cronin-Fenton, D. & Mortensen, F. V., Feb 2020, In: Cancer epidemiology. 64, 9 p., 101647.Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study
Rasmussen, L. S., Fristrup, C. W., Jensen, B. V., Pfeiffer, P., Weber, B., Yilmaz, M. K., Poulsen, L. Ø., Ladekarl, M., Østerlind, K., Larsen, J. S., Skuladottir, H., Hansen, C. P., Mortensen, M. B., Mortensen, F. V., Sall, M., Detlefsen, S., Bøgsted, M. & Falkmer, U. G., 2020, In: European Journal of Cancer. 129, p. 50-59 10 p.Tumor ulceration, reduced infiltration of CD8-lymphocytes, high neutrophil-to-CD8-lymphocyte ratio and absence of MC virus are negative prognostic markers for patients with merkel cell carcinoma
Naseri, S., Steiniche, T., Georgsen, J. B., Thomsen, R., Ladekarl, M., Heje, M., Damsgaard, T. E. & Bønnelykke-Behrndtz, M. L., 2020, In: Cancers. 12, 4, 11 p., 888.The effect of postoperative gemcitabine on overall survival in patients with resected pancreatic cancer: A nationwide population-based Danish register study
Skau Rasmussen, L., Vittrup, B., Ladekarl, M., Pfeiffer, P., Karen Yilmaz, M., Østergaard Poulsen, L., Østerlind, K., Palnæs Hansen, C., Bau Mortensen, M., Viborg Mortensen, F., Sall, M., Detlefsen, S., Bøgsted, M. & Wilki Fristrup, C., Jun 2019, In: Acta Oncologica. 58, 6, p. 864-871 8 p.Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature
Overby, A., Duval, L., Ladekarl, M., Laursen, B. E. & Donskov, F., Feb 2019, In: Clinical Genitourinary Cancer. 17, 1, p. e32-e37 6 p.Urban versus Rural Residency and Pancreatic Cancer Survival: A Danish Nationwide Population-based Cohort Study
Kirkegård, J., Ladekarl, M., Fristrup, C. W., Hansen, C. P., Sall, M. & Mortensen, F. V., 16 Aug 2018, In: PLOS ONE. 13, 8Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Ali, A. S., Grönberg, M., Langer, S. W., Ladekarl, M., Hjortland, G. O., Vestermark, L. W., Österlund, P., Welin, S., Grønbæk, H., Knigge, U., Sorbye, H. & Janson, E. T., 6 Mar 2018, In: Medical Oncology. 35, 4, p. 47Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study
Madsen, A. H., Ladekarl, M., Villadsen, G. E., Grønbæk, H., Sørensen, M. M., Stribolt, K., Verwaal, V. J. & Iversen, L. H., Feb 2018, In: Annals of Surgical Oncology. 25, 2, p. 422-430 9 p.Association of PD-L1 expression with prognosis among patients with 10 select cancers
Steiniche, T., Ladekarl, M., Bæhr Georgsen, J., Andreasen, S., Busch-Sørensen, M., Zhou, W., Pruitt, S. K., Joe, A. K. & Liaw, K-L., 2018, In: Annals of Oncology. 29, p. viii15Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas
Galleberg, R. B., Knigge, U., Tiensuu Janson, E., Vestermark, L. W., Haugvik, S-P., Ladekarl, M., Langer, S. W., Grønbæk, H., Österlund, P., Hjortland, G. O., Assmus, J., Tang, L., Perren, A. & Sorbye, H., Sept 2017, In: European Journal of Surgical Oncology. 43, 9, p. 1682-1689 8 p.Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
Ali, A. S., Grönberg, M., Federspiel, B., Scoazec, J-Y., Hjortland, G. O., Grønbæk, H., Ladekarl, M., Langer, S. W., Welin, S., Vestermark, L. W., Arola, J., Österlund, P., Knigge, U., Sorbye, H., Grimelius, L. & Janson, E. T., 2017, In: P L o S One. 12, 11, 15 p., e0187667.BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping
Sharma, M. B., Carus, A., Sunde, L., Hamilton-Dutoit, S. & Ladekarl, M., 2016, In: Acta Oncologica. p. 1-5 5 p.A Nationwide Retrospective Study of Perioperative Chemotherapy for Gastroesophageal Adenocarcinoma: Tolerability, Outcome, and Prognostic Factors
Larsen, A. C., Holländer, C., Duval, L., Schønnemann, K., Achiam, M., Pfeiffer, P., Yilmaz, M. K., Thorlacius-Ussing, O., Bæksgaard, L. & Ladekarl, M., May 2015, In: Annals of Surgical Oncology. 22, 5, p. 1540-1547 8 p.Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients
Olsen, I. H., Holt, N., Langer, S. W., Hasselby, J. P., Grønbæk, H., Hillingsø, J., Mahmoud, M., Ladekarl, M., Iversen, L. H., Kjær, A., Federspiel, B. H. & Knigge, U., 2015, In: PLOS ONE. 10, 2, p. e0117627Postoperative but not preoperative treatment with sorafenib inhibits liver regeneration in rats
Andersen, K. J., Knudsen, A. R., Kannerup, A-S., Nyengaard, J. R., Hamilton-Dutoit, S., Ladekarl, M. & Mortensen, F. V., 15 Apr 2014, In: The Journal of surgical research.Danish experiences with FOLFIRINOX as first-line therapy in patients with inoperable pancreatic cancer
Kræmer, P. C., Schmidt, H. H. & Ladekarl, M., Apr 2014, In: Danish Medical Journal. 61, 4, 4 p., A4819.Strong Prognostic Value of Tumor-infiltrating Neutrophils and Lymphocytes Assessed by Automated Digital Image Analysis in Early Stage Cervical Cancer: A Comparator Study with Observer-assisted Stereological Assessments
Carus, A., Donskov, F., Nielsen, P. S., Hager, H., Nedergaard, B., Steiniche, T. & Ladekarl, M., 2014, In: Journal of OncoPathology. 2, 2, p. 1-9 9 p.Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia
Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 15 Aug 2013, In: Journal of Translational Medicine. 11, 8, 10 p., 189.Advanced hepatocellular carcinoma in adolescence associated with congenital cholestasis: A case description
Ladekarl, M., Villadsen, G. E., Rudbeck, A. R., Aagenæs, Ø., Nielsen, J. E., Hamilton-Dutoit, S. & Nordsmark, M., 1 Jan 2013, In: Case Reports in Oncology. 6, 1, p. 98-103 6 p.Diffuse abdominal splenosis mimicking peritoneal metastases in a 35-year-old man with a resectable carcinoma of the ampulla of vater
Sorensen, S. F., Mortensen, F. V., Hellberg, Y. & Ladekarl, M., 2013, In: Case Reports in Oncology. 6, 3, p. 467-71 5 p.Sorafenib in advanced hepatocellular carcinoma: a nationwide retrospective study of efficacy and tolerability
Køstner, A. H., Sørensen, M., Olesen, R. K., Grønbæk, H., Lassen, U. & Ladekarl, M., 2013, In: Scientific World Journal. 2013, p. 931972Sorafenib inhibits liver regeneration in rats
Andersen, K. J., Knudsen, A. R., Kannerup, A-S., Sasanuma, H., Nyengaard, J. R., Hamilton-Dutoit, S., Ladekarl, M. & Mortensen, F. V., 2013, In: H P B. 15, 12, p. 944-950 7 p.Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome
Carus, A., Ladekarl, M., Hager, H., Pilegaard, H., Nielsen, P. S. & Donskov, F., 2013, In: Lung Cancer. 81, 1, p. 130-7 8 p.Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer
Carus, A., Ladekarl, M., Hager, H., Nedergaard, B. & Donskov, F., 2013, In: B J C. 108, 10, p. 2116-22 7 p.Dansk Pancreas Cancer Database
Fristrup, C., Palnæs Hansen, C., Ladekarl, M. & Mortensen, M. B., 2012, In: Ugeskrift for Læger. 174, 42, p. 2545 1 p.Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers
Rohrberg, K. S., Olesen, R. K., Pfeiffer, P., Ladekarl, M., Pappot, H., Christensen, I. J., Høyer-Hansen, G., Sørensen, M., Skov, B. G., Buysschaert, I., Carmeliet, P. & Lassen, U., 2012, In: Acta Oncologica. Supplement. 51, 2, p. 234-42 9 p.Malignant pheochromocytoma and paraganglioma: Three cases illustrating the use of molecular targeted diagnostics and therapy and possible role of new drugs
Zukauskaite, R., Hjorthgau, K., Poulsen, P. L., Baerentzen, S. & Ladekarl, M., 30 Jun 2011, In: Acta Oncologica. 50, 8, p. 1255-9 5 p.Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab
Rohrberg, K. S., Pappot, H., Lassen, U., Westman, M., Olesen, R. K., Pfeiffer, P., Ladekarl, M., Sørensen, M., Christensen, I. J. & Skov, B. G., 2011, In: Cancer Biology & Therapy. 11, 8, p. 732-9 8 p.Ovariemetastaser fra ventrikelcancer diagnosticeret med diffusionsvægtet 3T-magnetisk resonans-skanning
Røhl, L., Nellemann, H. M., Ladekarl, M. & Pedersen, E. M., 2011, In: Ugeskrift for Laeger. 173, 16-17, p. 1212-3 2 p.Onkologisk behandling af patienter med pancreascancer
Ladekarl, M., Jensen, B. V. & Pfeiffer, P., 3 May 2010, In: Ugeskrift for Laeger. 172, 18, p. 1373-6 4 p.A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years
Nedergaard, B., Ladekarl, M., Nyengaard, J. R. & Nielsen, K., 2008, In: Gynecologic Oncology. 108, 1, p. 106-111 6 p.Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
Nedergaard, B. S., Ladekarl, M., Thomsen, H. F., Nyengaard, J. R. & Nielsen, K., 2007, In: British Journal of Cancer. 97, 8, p. 1135-8 3 p.Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri
Nedergaard, B., Nielsen, K., Nyengaard, J. R. & Ladekarl, M., 2007, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 115, 12, p. 1321-30 9 p.Detection of circulating tumour lysate-reactive CD4+ T cells in melanoma patients
Ladekarl, M., Agger, R., Fleischer, C. C., Hokland, M., Hulgaard, E. F., Kirkin, A., von der Maase, H., Petersen, M. S., Rytter, C., Zeuthen, J. & Gundersen, H. J. G., 2004, In: Cancer Immunology, Immunotherapy. 53, p. 560-566 7 p.Measurements of hypoxia using pimonidazole and polarograhpic oxygen-sensitive electrodes in human cervix carcinomas
Nordsmark, M., Loncaster, J., Aquino-Parsons, C., Chou, S-C., Ladekarl, M., Havsteen, H., Lindegaard, J. C., Davidson, S. E., Varia, M., West, C., Hunter, R., Overgaard, J. & Raleigh, J. A., Apr 2003, In: Radiotherapy & Oncology. 67, 1, p. 35-44 10 p.Nye behandlingsperspektiver ved duktalt carcinoma in situ mammae
Ladekarl, M., Grau, C. & Andersen, J., 10 Sept 2001, In: Ugeskrift for Laeger. 163, 37, p. 5014-7 4 p.Nye behandlingsperspektiver ved duktalt carcinoma in situ mammae: New therapeutic perspectives in breast ductal carcinoma in situ
Ladekarl, M., Grau, C. & Andersen, J., 2001, In: Ugeskrift for Laeger. 163, 37, p. 5014-5017 4 p., 4979.The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors
Horsman, M. R., Ehrnrooth, E., Ladekarl, M. & Overgaard, J., 1 Nov 1998, In: International Journal of Radiation Oncology, Biology, Physics. 42, 4, p. 895-898 4 p.Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas
Jensen, V., Sørensen, F. B., Bentzen, S. M., Ladekarl, M., Nielsen, O. S., Keller, J. & Jensen, O. M., Jun 1998, In: Histopathology. 32, 6, p. 536-46 11 p.The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer
Jensen, V., Ladekarl, M., Holm-Nielsen, P., Melsen, F. & Sørensen, F. B., Aug 1995, In: Journal of Pathology. 176, 4, p. 343-352 10 p.Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast
Ladekarl, M. & Sørensen, F. B., Dec 1993, In: APMIS Supplementum. 101, 12, p. 895-903 9 p.Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast
Ladekarl, M. & Sørensen, F. B., 1 Nov 1993, In: Cancer. 72, 9, p. 2602-2611 10 p.Prognostic value of nucleolar size and size pleomorphism in choroidal melanomas
Sørensen, F. B., Gamel, J. W., Jensen, O. A., Ladekarl, M. & McCurdy, J., May 1993, In: APMIS Supplementum. 101, 5, p. 358-368 11 p.